Integrated Pharma Distributors Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-07-2024
- Paid Up Capital ₹ 1.60 M
as on 03-07-2024
- Company Age 27 Year, 3 Months
- Last Filing with ROC 31 Mar 2008
- Open Charges ₹ 3.00 Cr
as on 03-07-2024
- Satisfied Charges ₹ 2.50 Cr
as on 03-07-2024
About Integrated Pharma Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2008. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 1.60 M.
The company currently has active open charges totaling ₹3.00 Cr. The company has closed loans amounting to ₹2.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Allath Kumar and Kulasekharan Parusuraman serve as directors at the Company.
- CIN/LLPIN
U51909TN1997PTC039041
- Company No.
039041
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Sep 1997
- Date of AGM
29 Sep 2008
- Date of Balance Sheet
31 Mar 2008
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Integrated Pharma Distributors?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Allath Kumar  | Managing Director | 17-Sep-1997 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Kulasekharan Parusuraman | Additional Director | 01-Apr-2010 | Current |
Financial Performance of Integrated Pharma Distributors.
Enhance accessibility to Integrated Pharma Distributors's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Integrated Pharma Distributors?
Unlock access to Integrated Pharma Distributors's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 28 Sep 2010 | ₹3.00 Cr | Open |
Bank Of Baroda Creation Date: 31 Oct 2003 | ₹2.50 Cr | Satisfied |
How Many Employees Work at Integrated Pharma Distributors?
Unlock and access historical data on people associated with Integrated Pharma Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Integrated Pharma Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Integrated Pharma Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
